Metastatic Gastric Adenocarcinoma Recruiting Phase 2 Trials for Lexatumumab (DB06599)

Also known as: Adenocarcinoma gastric / Adenocarcinoma of stomach (disorder)

IndicationStatusPhase
DBCOND0074521 (Metastatic Gastric Adenocarcinoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04660760Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction CancerTreatment